about
Predictors of health care use among patients with or at high risk of atherothrombotic disease: two-year follow-up data.The effectiveness and cost effectiveness of dark chocolate consumption as prevention therapy in people at high risk of cardiovascular disease: best case scenario analysis using a Markov model.Interventions that cause weight loss and the impact on cardiovascular risk factors: a systematic review and meta-analysis.Evaluating the clinical and cost effectiveness of a behaviour change intervention for lowering cardiovascular disease risk for people with severe mental illnesses in primary care (PRIMROSE study): study protocol for a cluster randomised controlled tOverview of pharmacoeconomic modelling methods.Patterns and Predictors of Adherence to Statin Therapy Among Older Patients: Protocol for a Systematic Review.Effectiveness and cost-effectiveness of interventions that cause weight loss and reduce the risk of cardiovascular disease.Effectiveness and cost-effectiveness of a cardiovascular risk prediction algorithm for people with severe mental illness (PRIMROSE).Cardiovascular risk prediction in a population with the metabolic syndrome: Framingham vs. UKPDS algorithms.Validation of two Framingham cardiovascular risk prediction algorithms in an Australian population: the 'old' versus the 'new' Framingham equation.Can oral vitamin D prevent the cardiovascular diseases among migrants in Australia? Provider perspective using Markov modelling.Effect of urotensin II on skin microvessel tone in diabetic patients without heart failure or essential hypertension.Predicting the impact of polypill use in a metabolic syndrome population: an effectiveness and cost-effectiveness analysis.A Systematic Review and Meta-analysis of the Factors Associated With Nonadherence and Discontinuation of Statins Among People Aged ≥65 Years.Forecasting the future burden of opioids for osteoarthritis.Adherence and Persistence among Statin Users aged 65 years and over: A Systematic Review and Meta-analysis.The Productivity Burden of Diabetes at a Population Level.Patterns of Statin Use and Long-term Adherence and Persistence among Older Adults with Diabetes.Self-sampling kits to increase HIV testing among black Africans in the UK: the HAUS mixed-methods study.Could low birth weight and preterm birth be associated with significant burden of hip osteoarthritis? A systematic review.Outcomes and Excess Costs among Patients with Cardiovascular DiseaseCost-Effectiveness of Renal Denervation Therapy for Treatment-Resistant Hypertension: A Best Case ScenarioPredictors of first-year nonadherence and discontinuation of statins among older adults: a retrospective cohort studyThe projected burden of primary total knee and hip replacement for osteoarthritis in Australia to the year 2030The cost-effectiveness of PCSK9 inhibitors - The Australian healthcare perspectiveA 10-Year Trend in Statin Use Among Older Adults in Australia: an Analysis Using National Pharmacy Claims DataPrevalence and Incidence of Statin Use and 3-Year Adherence and Discontinuation Rates Among Older Adults With DementiaProductivity burden of smoking in Australia: a life table modelling studyCost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: An Australian healthcare perspectiveImpact of tobacco use on health and work productivity in MalaysiaThe cost-effectiveness of canakinumab for secondary prevention of cardiovascular disease: The Australian healthcare perspectiveProductivity Burden of Hypertension in AustraliaPredictors of statin use among older adults: A nationwide cross-sectional studySwitching, Discontinuation, and Reinitiation of Statins Among Older AdultsStatins for people at low risk of cardiovascular diseasePrimary care management of cardiovascular risk for people with severe mental illnesses: the Primrose research programme including cluster RCT
P50
Q30818646-FD14841A-392D-4391-8464-8833AE34207AQ36001140-68512AD0-04A8-46FB-A0AD-6996E2624B14Q36057310-23C4533A-8EED-4BFF-8F37-8C30B6CC841EQ36574892-FCCD5C76-313D-4BDC-91DB-8B38E73CE509Q36729904-5A0E1DCA-A6BA-4844-8F55-D8F227503137Q37714650-BB372812-8E7E-414A-BA4E-6E9AD07B9F9EQ39633381-C66E6861-793C-4667-B02D-7588CA5F27F8Q40055142-8716E6BC-6B3E-4852-BA3E-FC6326E64E97Q43426604-56996BF4-1036-45FC-BB46-45314D0856CFQ44422852-BA3ACEDC-AB95-4267-8E9C-D306DAB2F03DQ44954648-F00EA7BD-9353-4E3C-8A18-92526AF1F2E9Q45274809-B4B1C7A0-5D23-4AC2-ABF7-0FC6379C2502Q46339266-FB4F5F93-ECE9-463D-B957-AB9B340CB26BQ47550011-5F9750BF-0DC9-4FE7-89CD-8A14DA7D6294Q47611111-9FF0CD36-F1CB-4903-AEBA-9EB91C72A6D2Q47906320-02D5D740-A3EE-49C7-9333-350964E49926Q51746333-F577E5EE-6700-43DF-ACB4-A381B571742EQ52586940-FD1E03E8-824F-4946-8962-C0308C8872CFQ52801407-7486947D-CA97-4092-A21F-C028FCA6F339Q55476851-70D77394-2358-48B5-9DF7-8AD1FFA5214BQ57193532-0A702C2E-A8FD-4527-B964-5BC72455A91BQ58463405-12254FB4-F413-414C-9F7D-42DA0EA43E8EQ58605825-7699860F-E90F-4B72-AB47-BF322E3A33E5Q64108044-C03195F4-132A-43F2-A03F-1A9C841D03AFQ88582714-48A502A4-1470-44BC-9682-2920C7182225Q88780214-C7013438-E81A-4155-9B19-381EE8264124Q89503509-92094546-7E20-467C-959D-2E602EDE944CQ90252826-7417C5A3-FA94-4810-86F5-BEC04F04022EQ90333751-0E099214-78ED-48E7-A452-A9B25CE4C9BEQ90891747-6E5E4FC5-7354-49A6-AA62-4A348F53860BQ91240975-E8330685-0978-4FE4-95FB-B90A8F3DA365Q91862568-D428D838-FBE8-4B1F-9093-B1096D718FF2Q93182005-C5EC2EB4-A23F-41EE-BACC-9391D89670F3Q93353879-945EFB4A-9781-45F6-97C3-A562E1F40B35Q95460925-3BDB0B93-7818-42F1-95D0-F238CC00F742Q95472493-B873F59B-1A68-43FF-8392-46A5E5B3BB43
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ella Zomer
@ast
Ella Zomer
@en
Ella Zomer
@es
Ella Zomer
@nl
Ella Zomer
@sl
type
label
Ella Zomer
@ast
Ella Zomer
@en
Ella Zomer
@es
Ella Zomer
@nl
Ella Zomer
@sl
prefLabel
Ella Zomer
@ast
Ella Zomer
@en
Ella Zomer
@es
Ella Zomer
@nl
Ella Zomer
@sl
P106
P1153
23101858900
P21
P31
P496
0000-0002-9993-4297